190 related articles for article (PubMed ID: 38250157)
41. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.
Zhao CX; Yan ZX; Wen JJ; Fu D; Xu PP; Wang L; Cheng S; Hu JD; Zhao WL
Mol Cancer; 2021 Dec; 20(1):153. PubMed ID: 34852843
[TBL] [Abstract][Full Text] [Related]
42. Codonopsis pilosula-derived glycopeptide dCP1 promotes the polarization of tumor-associated macrophage from M2-like to M1 phenotype.
Liu H; Yao M; Ren J
Cancer Immunol Immunother; 2024 May; 73(7):128. PubMed ID: 38743074
[TBL] [Abstract][Full Text] [Related]
43. Lung adenocarcinoma cell-derived exosomes promote M2 macrophage polarization through transmission of miR-3153 to activate the JNK signaling pathway.
Xu L; Wang L; Yang R; Li T; Zhu X
Hum Mol Genet; 2023 Jun; 32(13):2162-2176. PubMed ID: 37010098
[TBL] [Abstract][Full Text] [Related]
44. Exosomal ncRNAs facilitate interactive 'dialogue' between tumor cells and tumor-associated macrophages.
Zhou X; Liu Q; Wang X; Yao X; Zhang B; Wu J; Sun C
Cancer Lett; 2023 Jan; 552():215975. PubMed ID: 36306940
[TBL] [Abstract][Full Text] [Related]
45. Hepatocellular Carcinoma Cell-Derived Exosomal miR-21-5p Induces Macrophage M2 Polarization by Targeting RhoB.
Yu H; Pan J; Zheng S; Cai D; Luo A; Xia Z; Huang J
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902024
[TBL] [Abstract][Full Text] [Related]
46. Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis.
Yang C; Dou R; Wei C; Liu K; Shi D; Zhang C; Liu Q; Wang S; Xiong B
Mol Ther; 2021 Jun; 29(6):2088-2107. PubMed ID: 33571679
[TBL] [Abstract][Full Text] [Related]
47. Ovatodiolide, isolated from Anisomeles indica, suppresses bladder carcinogenesis through suppression of mTOR/β-catenin/CDK6 and exosomal miR-21 derived from M2 tumor-associated macrophages.
Wu ATH; Srivastava P; Yadav VK; Tzeng DTW; Iamsaard S; Su EC; Hsiao M; Liu MC
Toxicol Appl Pharmacol; 2020 Aug; 401():115109. PubMed ID: 32544403
[TBL] [Abstract][Full Text] [Related]
48. M2-Macrophage-Derived Exosomes Promote Meningioma Progression through TGF-
Fu XH; Li JP; Li XY; Tan Y; Zhao M; Zhang SF; Wu XD; Xu JG
J Immunol Res; 2022; 2022():8326591. PubMed ID: 35637794
[TBL] [Abstract][Full Text] [Related]
49. Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line.
Moradi-Chaleshtori M; Bandehpour M; Heidari N; Mohammadi-Yeganeh S; Mahmoud Hashemi S
Int Immunopharmacol; 2021 Jan; 90():107198. PubMed ID: 33249048
[TBL] [Abstract][Full Text] [Related]
50. Cancer-Associated Fibroblast-Derived Exosomal miRNA-320a Promotes Macrophage M2 Polarization
Zhao M; Zhuang A; Fang Y
J Oncol; 2022; 2022():9514697. PubMed ID: 35813857
[TBL] [Abstract][Full Text] [Related]
51. Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma.
Dai L; Fan G; Xie T; Li L; Tang L; Chen H; Shi Y; Han X
Biomark Res; 2024 Jun; 12(1):58. PubMed ID: 38840205
[TBL] [Abstract][Full Text] [Related]
52. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.
Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ
J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401
[TBL] [Abstract][Full Text] [Related]
53. Inflammatory Periodontal Ligament Stem Cells Drive M1 Macrophage Polarization via Exosomal miR-143-3p-Mediated Regulation of PI3K/AKT/NF-κB Signaling.
Wang Y; Zhang X; Wang J; Zhang Y; Ye Q; Wang Y; Fei D; Wang Q
Stem Cells; 2023 Mar; 41(2):184-199. PubMed ID: 36520505
[TBL] [Abstract][Full Text] [Related]
54. Exosomal miR-222 from adriamycin-resistant MCF-7 breast cancer cells promote macrophages M2 polarization via PTEN/Akt to induce tumor progression.
Chen WX; Wang DD; Zhu B; Zhu YZ; Zheng L; Feng ZQ; Qin XH
Aging (Albany NY); 2021 Mar; 13(7):10415-10430. PubMed ID: 33752173
[TBL] [Abstract][Full Text] [Related]
55. Tumor-Derived Exosomal Protein Tyrosine Phosphatase Receptor Type O Polarizes Macrophage to Suppress Breast Tumor Cell Invasion and Migration.
Dong H; Xie C; Jiang Y; Li K; Lin Y; Pang X; Xiong X; Zheng J; Ke X; Chen Y; Li Y; Zhang H
Front Cell Dev Biol; 2021; 9():703537. PubMed ID: 34650968
[TBL] [Abstract][Full Text] [Related]
56. M2 macrophage-derived exosomal miR-193b-3p promotes progression and glutamine uptake of pancreatic cancer by targeting TRIM62.
Zhang K; Li YJ; Peng LJ; Gao HF; Liu LM; Chen H
Biol Direct; 2023 Jan; 18(1):1. PubMed ID: 36631876
[TBL] [Abstract][Full Text] [Related]
57. M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages.
Gunassekaran GR; Poongkavithai Vadevoo SM; Baek MC; Lee B
Biomaterials; 2021 Nov; 278():121137. PubMed ID: 34560422
[TBL] [Abstract][Full Text] [Related]
58. TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway.
Jiang M; Wang D; Su N; Lou W; Chen Y; Yang H; Chen C; Xi F; Chen Y; Deng L; Tang X
Int Immunopharmacol; 2024 Feb; 128():111494. PubMed ID: 38218012
[TBL] [Abstract][Full Text] [Related]
59. Macrophage-Derived Exosomal miR-31-5p Promotes Oral Squamous Cell Carcinoma Tumourigenesis Through the Large Tumor Suppressor 2-Mediated Hippo Signalling Pathway.
Yuan Y; Wang Z; Chen M; Jing Y; Shu W; Xie Z; Li Z; Xu J; He F; Jiao P; Wang J; Xu J; Xia Y; Liu S; Du H; Li H; Dai L; Dai Y; Zhang Y
J Biomed Nanotechnol; 2021 May; 17(5):822-837. PubMed ID: 34082869
[TBL] [Abstract][Full Text] [Related]
60. ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway.
Xu D; Wang Y; Wu J; Zhang Z; Chen J; Xie M; Tang R; Chen C; Chen L; Lin S; Luo X; Zheng J
Cell Death Dis; 2021 Feb; 12(2):162. PubMed ID: 33558466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
